ACB
Aurora CannabisACB
ACB
About: Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.
Employees: 1,130
0
Funds holding %
of 6,831 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
67% more call options, than puts
Call options by funds: $47.2M | Put options by funds: $28.3M
15% more capital invested
Capital invested by funds: $18.4M [Q2] → $21.2M (+$2.79M) [Q3]
0.71% less ownership
Funds ownership: 7.29% [Q2] → 6.58% (-0.71%) [Q3]
13% less funds holding
Funds holding: 163 [Q2] → 142 (-21) [Q3]
18% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 34
58% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 31
Research analyst outlook
We haven’t received any recent analyst ratings for ACB.
Financial journalist opinion
Based on 7 articles about ACB published over the past 30 days
Positive
Zacks Investment Research
4 hours ago
Aurora Cannabis Inc. (ACB) Surpasses Q3 Earnings and Revenue Estimates
Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to loss of $0.20 per share a year ago.
Positive
Benzinga
4 hours ago
Aurora Cannabis Stock Jumps On 'Record-Breaking' Q3 Earnings
Canada-based global medical cannabis company Aurora Cannabis Inc ACB reported a third-quarter fiscal 2025 net revenue of CA$88.2 million, compared to CA$64.4 million a year ago.
Neutral
PRNewsWire
6 hours ago
Aurora Cannabis Announces Fiscal 2025 Third Quarter Results
NASDAQ | TSX: ACB Reports Total Net Revenue1 of $88.2 Million, up 37% YoY, Including Record Net Revenue1 of $68.1 Million in Global Medical Cannabis, up 51% YoY Generates Record Net Income of $31.2 Million, up 282% YoY, and Record Adjusted EBITDA1 of $23.1 Million, up 316% YoY Achieves Target of Positive Free Cash Flow1 in Q3, Generating $27.4 Million of Free Cash Flow1 Maintains Strong Balance Sheet with $180 Million of Cash and Debt-Free Cannabis Business2 EDMONTON, AB , Feb. 5, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the third quarter fiscal 2025. "This quarter was record-breaking for Aurora, driven by all-time highs in global medical net revenue1, net income, adjusted EBITDA1, and free cash flow1.
Neutral
PRNewsWire
1 week ago
Aurora Cannabis Launches First Domestically Grown Medical Cannabis Brand in Germany Under New Cultivation License
NASDAQ | TSX: ACB Investment in the region continues with the launch of IndiMed, the company's first locally grown brand in Germany EDMONTON, AB , Jan. 23, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces today the launch of the company's first German-cultivated medical cannabis product, under the brand IndiMed. Manufactured at Aurora's leading EU-GMP facility in Leuna, Germany, the new brand offers a supply of high-quality, locally grown and sold, medical cannabis for the country's expanding patient base.
Neutral
PRNewsWire
1 week ago
Aurora Cannabis to Host Third Quarter 2025 Investor Conference Call
NASDAQ | TSX: ACB EDMONTON, AB , Jan. 22, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its third quarter 2025 on Wednesday, February 5, 2025 at 8:00 a.m. Eastern Time | 6:00 a.m.
Positive
MarijuanaStocks
2 weeks ago
Top Canadian Cannabis Companies Poised for Market Growth in 2025
The cannabis industry remains a rapidly expanding sector, with significant growth expected in the coming years. In the United States alone, legal cannabis sales surpassed $25 billion in 2021 and are projected to reach $50 billion by 2026. This impressive growth is fueled by increasing state-level legalization and the potential for federal reform. Recent headlines, including bipartisan efforts to reschedule cannabis and banking legislation advancements, have renewed investor optimism. As Canadian cannabis companies eye the lucrative U.S. market, their innovative strategies and cross-border partnerships position them for potential success. This week, top Canadian cannabis stocks, including Aurora Cannabis, Cronos Group, and Sundial Growers, are worth watching closely.
Neutral
PRNewsWire
3 weeks ago
Empowering the Next Generation: Aurora Announces German Internship Program
NASDAQ | TSX: ACB Company Launches Internships at Manufacturing Facility in Leuna, Germany to Cultivate Future Leaders in the Medical Cannabis Industry EDMONTON, AB , Jan. 10, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the launch of an internship program at Aurora's leading EU-GMP facility in Leuna, Germany. In partnership with Erfurt University of Applied Sciences, students of the Horticultural Crop Production course will gain valuable hands-on experience on-site and deepen their understanding of medical cannabis cultivation.
Negative
Market Watch
1 month ago
Cannabis sector limps into 2025 because ‘the gold rush is over'
Investors owning cannabis stocks will no doubt hope for a reversal of fortunes in 2025 after a year of bruising losses in equity prices tied to the business of legalized marijuana in the U.S.
Positive
MarijuanaStocks
1 month ago
2025 Outlook: The Best Canadian Cannabis Stocks to Watch Now
The cannabis industry continues to evolve rapidly, presenting unique investment opportunities, especially in Canadian cannabis stocks. With the U.S. cannabis market projected to exceed $40 billion by 2025, legalization efforts are gaining traction. Recent news highlights growing bipartisan support for federal cannabis reform in the U.S., which could further boost industry expansion. Canadian cannabis companies, with their well-established infrastructure and international presence, are strategically positioned to capitalize on this growth. Tracking key stocks with solid fundamentals and technical setups becomes essential as investors look for potential gains.
Neutral
The Motley Fool
1 month ago
Better Marijuana Stock: Aurora Cannabis or Tilray Brands?
The global cannabis market tells a tale of survival and adaptation. After a brutal multiyear shakeout that saw dozens of companies fold or merge, the remaining players have emerged battle-tested and strategically transformed.
Charts implemented using Lightweight Charts™